MAPK1 and infection: Analysis of the expression of virus-encoded proteins showed that the use of p38-MAPK inhibitors reduces the expression of BZLF1 and BGLF2-induced virus replication, indicating that EBV can enhance its own infection ability through the p38-MAPK signaling pathway [47].